Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL224864 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
sirtuin 1/NAD-dependent deacetylase sirtuin 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4506] [GtoPdb: 2707] [UniProtKB: Q96EB6] | ||||||||
ChEMBL | Inhibition of N-terminal His-tagged recombinant human SIRT-1 expressed in Escherichia coli using Fluor-de-Lys-SIRT1 as substrate after 15 mins by fluorescence assay | B | 4.01 | pIC50 | 98100 | nM | IC50 | J Med Chem (2017) 60: 4714-4733 [PMID:28475330] |
ChEMBL | Inhibition of recombinant human N-terminal GST-tagged SIRT1 (193 to 741 residues) using human p53 derived peptides as substrate incubated for 45 mins by fluorescence assay | B | 4.17 | pIC50 | 68000 | nM | IC50 | Medchemcomm (2015) 6: 1857-1863 |
ChEMBL | Inhibition of human recombinant SIRT1 using fluorescent peptide substrate by fluorescent assay | B | 4.3 | pIC50 | >50000 | nM | IC50 | Science (2007) 317: 516-519 [PMID:17588900] |
ChEMBL | Inhibition of human recombinant SIRT1 by Flour de Lys assay | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2010) 53: 1407-1411 [PMID:20041717] |
ChEMBL | Inhibition of human SIRT1 | B | 4.3 | pIC50 | >50000 | nM | IC50 | Bioorg Med Chem (2015) 23: 328-339 [PMID:25515955] |
ChEMBL | Inhibition of human SIRT1 | B | 4.3 | pIC50 | >50000 | nM | IC50 | J Med Chem (2017) 60: 1928-1945 [PMID:28135086] |
ChEMBL | Inhibition of human recombinant SIRT1 expressed in Escherichia coli cells using acetylated Lys side chain amino acids 379-382 (Arg-His-Lys-Lys(Ac)) p53 conjugated with aminomethylcoumarin as substrate by fluorescence assay | B | 4.42 | pIC50 | 38000 | nM | IC50 | J Med Chem (2012) 55: 8193-8197 [PMID:22931526] |
ChEMBL | Inhibition of human recombinant SIRT1 using Fluor-de-Lys as substrate incubated for 60 mins prior to substrate addition measured after 60 mins by fluorometric analysis | B | 4.52 | pIC50 | 30000 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 1871-1874 [PMID:24675380] |
ChEMBL | Inhibition of human recombinant SIRT1 using Fluor de Lys-SIRT as substrate incubated for 60 mins prior to substrate addition measured after 60 mins by fluorimetric analysis | B | 4.52 | pIC50 | 30000 | nM | IC50 | J Med Chem (2012) 55: 5760-5773 [PMID:22642300] |
sirtuin 2/NAD-dependent deacetylase sirtuin 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4462] [GtoPdb: 2708] [UniProtKB: Q8IXJ6] | ||||||||
ChEMBL | Inhibition of GST-tagged SIRT2 (unknown origin) by HPLC assay | B | 4.26 | pIC50 | 55000 | nM | IC50 | Medchemcomm (2010) 1: 233-238 |
ChEMBL | Inhibition of human recombinant SIRT2 assessed as deacetylation of N-acetyl lysine residue in p53 (317 to 320) after 30 mins by luciferase-mediated luminescence assay | B | 4.86 | pIC50 | 13900 | nM | IC50 | Eur J Med Chem (2015) 92: 145-155 [PMID:25549554] |
ChEMBL | Inhibition of human recombinant SIRT2 using AMC-p53 (317 to 320 residues) as substrate incubated for 45 mins followed by NAD+ addition measured after 30 mins by fluorescence assay | B | 5.08 | pIC50 | 8340 | nM | IC50 | Medchemcomm (2016) 7: 2094-2099 |
ChEMBL | Inhibition of human recombinant SIRT2 using p53 (317 to 320 residues) conjugated to AMC as substrate incubated for 45 mins in presence of NAD+ by fluorescence assay | B | 5.08 | pIC50 | 8340 | nM | IC50 | Medchemcomm (2019) 10: 2140-2145 [PMID:32904142] |
ChEMBL | Inhibition of recombinant human C-terminal His-tagged SIRT2 (13 to 319 residues) using human p53 derived peptides as substrate incubated for 45 mins by fluorescence assay | B | 5.1 | pIC50 | 7900 | nM | IC50 | Medchemcomm (2015) 6: 1857-1863 |
ChEMBL | Inhibition of human recombinant SIRT2 expressed in Escherichia coli cells using acetylated Lys side chain amino acids 379-382 (Arg-His-Lys-Lys(Ac)) p53 conjugated with aminomethylcoumarin as substrate by fluorescence assay | B | 5.26 | pIC50 | 5500 | nM | IC50 | J Med Chem (2012) 55: 8193-8197 [PMID:22931526] |
ChEMBL | Inhibition of human recombinant SIRT2 by Flour de Lys assay | B | 5.45 | pIC50 | 3540 | nM | IC50 | J Med Chem (2010) 53: 1407-1411 [PMID:20041717] |
ChEMBL | Inhibition of human recombinant SIRT2 | B | 5.46 | pIC50 | 3500 | nM | IC50 | Bioorg Med Chem (2015) 23: 328-339 [PMID:25515955] |
ChEMBL | Inhibition of human SIRT2 | B | 5.46 | pIC50 | 3500 | nM | IC50 | J Med Chem (2017) 60: 1928-1945 [PMID:28135086] |
ChEMBL | Inhibition of SIRT-2 (unknown origin) | B | 5.46 | pIC50 | 3500 | nM | IC50 | Medchemcomm (2012) 3: 135-161 |
ChEMBL | Inhibition of SirT2 | B | 5.46 | pIC50 | 3500 | nM | IC50 | Nat Chem Biol (2008) 4: 590-597 [PMID:18800048] |
ChEMBL | Inhibition of SIRT2 | B | 5.46 | pIC50 | 3500 | nM | IC50 | Bioorg Med Chem (2011) 19: 3616-3624 [PMID:21306906] |
ChEMBL | Inhibition of Sirt2 | B | 5.46 | pIC50 | 3500 | nM | IC50 | Bioorg Med Chem (2011) 19: 3605-3615 [PMID:21316248] |
ChEMBL | Inhibition of human recombinant SIRT2 using Fluor de Lys-SIRT as substrate incubated for 60 mins prior to substrate addition measured after 60 mins by fluorimetric analysis | B | 5.46 | pIC50 | 3500 | nM | IC50 | J Med Chem (2012) 55: 5760-5773 [PMID:22642300] |
ChEMBL | Inhibition of human recombinant SIRT2 using Fluor-de-Lys as substrate incubated for 60 mins prior to substrate addition measured after 60 mins by fluorometric analysis | B | 5.46 | pIC50 | 3500 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 1871-1874 [PMID:24675380] |
ChEMBL | Inhibition of human recombinant SIRT2 using fluorescent peptide substrate by fluorescent assay | B | 5.46 | pIC50 | 3500 | nM | IC50 | Science (2007) 317: 516-519 [PMID:17588900] |
ChEMBL | Inhibition of GST-tagged human recombinant SIRT2 (34 to 356 residues) expressed in Escherichia coli BL21 using Fluor de Lys-SIRT as substrate incubated for 60 mins prior to substrate addition measured after 45 mins by fluorimetric analysis | B | 5.52 | pIC50 | 3000 | nM | IC50 | Bioorg Med Chem (2015) 23: 328-339 [PMID:25515955] |
ChEMBL | Inhibition of N-terminal His-tagged recombinant human SIRT-2 expressed in Escherichia coli using Fluor-de-Lys-SIRT1 as substrate after 15 mins by fluorescence assay | B | 5.55 | pIC50 | 2800 | nM | IC50 | J Med Chem (2017) 60: 4714-4733 [PMID:28475330] |
ChEMBL | Inhibition of full length human SIRT2 expressed in Escherichia coli BL21 (DE3) cells using fluorogenic 7-amino-4-methylcoumarin (AMC)-labeled peptide by fluorescence assay | B | 5.81 | pIC50 | 1560 | nM | IC50 | J Med Chem (2014) 57: 8340-8357 [PMID:25275824] |
GtoPdb | - | - | 5.81 | pIC50 | 1560 | nM | IC50 |
Science (2007) 317: 516-9 [PMID:17588900]; J Med Chem (2014) 57: 8340-57 [PMID:25275824] |
sirtuin 3/NAD-dependent deacetylase sirtuin 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4461] [GtoPdb: 2709] [UniProtKB: Q9NTG7] | ||||||||
ChEMBL | Inhibition of human recombinant SIRT3 using Fluor de Lys-SIRT as substrate incubated for 60 mins prior to substrate addition measured after 60 mins by fluorimetric analysis | B | 4.04 | pIC50 | 91000 | nM | IC50 | J Med Chem (2012) 55: 5760-5773 [PMID:22642300] |
ChEMBL | Inhibition of human recombinant SIRT3 using Fluor-de-Lys as substrate incubated for 60 mins prior to substrate addition measured after 60 mins by fluorometric analysis | B | 4.04 | pIC50 | 91000 | nM | IC50 | Bioorg Med Chem Lett (2014) 24: 1871-1874 [PMID:24675380] |
ChEMBL | Inhibition of catalytically active human SIRT3 (102 to 399 amino acids) expressed in Escherichia coli BL21 (DE3) cells using fluorogenic 7-amino-4-methylcoumarin (AMC)-labeled peptide by fluorescence assay | B | 4.28 | pIC50 | 52800 | nM | IC50 | J Med Chem (2014) 57: 8340-8357 [PMID:25275824] |
ChEMBL | Inhibition of human recombinant SIRT3 using fluorescent peptide substrate by fluorescent assay | B | 4.3 | pIC50 | >50000 | nM | IC50 | Science (2007) 317: 516-519 [PMID:17588900] |
ChEMBL | Inhibition of human SIRT3 | B | 4.3 | pIC50 | >50000 | nM | IC50 | Bioorg Med Chem (2015) 23: 328-339 [PMID:25515955] |
sirtuin 5/NAD-dependent protein deacylase sirtuin-5, mitochondrial in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2163183] [GtoPdb: 2711] [UniProtKB: Q9NXA8] | ||||||||
ChEMBL | Inhibition of SIRT5 | B | 4 | pIC50 | >100000 | nM | IC50 | J Med Chem (2012) 55: 5582-5590 [PMID:22583019] |
ChEMBL | Inhibition of human SIRT5 assessed as reduction in desuccinylase activity using KQTAR(SuK)STGGKA substrate | B | 4 | pIC50 | >100000 | nM | IC50 | Bioorg Med Chem Lett (2015) 25: 1671-1674 [PMID:25818461] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]